Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Exclusivity Extended into December 2042 Exclusivity Extended into December 2042

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.